Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Antiprotozoal Lysophospholipid Analogues: A Comparison of their Activity Against Trypanosomatid Parasites and Tumor Cells

Author(s): S. L. de Castro, R. M. Santa-Rita, J. A. Urbina and S. L. Croft

Volume 4, Issue 2, 2004

Page: [141 - 151] Pages: 11

DOI: 10.2174/1389557043487439

Price: $65

Abstract

Lysophospholipid analogues (LPAs), originally developed as anti-cancer agents, have shown significant activity against Leishmania spp. and Trypanosoma cruzi, both in vitro and in vivo. Miltefosine, used as a topical formulation (Miltex™) for metastases, was registered in 2002 for the oral treatment of visceral leishmaniasis. LPAs interfere with lipid synthesis in T. cruzi and cancer cells, but the activity is about > 20- fold higher against the parasite.

Keywords: Antiprotozoal, Lysophospholipid, Trypanosoma cruzi, leishmaniasis


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy